Sign In
Buy MBII
$0.798
+0 (+0%)
At Close: Nov 04, 2022
Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions
04:43pm, Tuesday, 12'th Jul 2022
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions completes merger with Madrone Bio, creating a global leader in sustainable agricultural solutions
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.
08:30am, Monday, 11'th Jul 2022
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved
Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1
02:18pm, Tuesday, 17'th May 2022
Marrone Bio (MBII) witnessed increased sales of row crop products in the first quarter, offset by lower sales into specialty crop markets.
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q1 2022 Results - Earnings Call Transcript
08:01pm, Wednesday, 11'th May 2022
Marrone Bio Innovations, Inc. (NASDAQ:MBII ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Kevin Helash – Chief Executive Officer Linda Moore – Chief Legal Officer
Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates
06:49pm, Wednesday, 11'th May 2022
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of -300% and 8.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results
04:01pm, Wednesday, 11'th May 2022
RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financia
MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII
04:05pm, Wednesday, 04'th May 2022
CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the t
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Marrone Bio
Marrone Bio Innovations, Inc. (MBII) Reports Q4 Loss, Tops Revenue Estimates
12:25am, Tuesday, 29'th Mar 2022 Zacks Investment Research
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0% and 3.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s
Marrone Bio Innovations, Inc. (MBII) Reports Q4 Loss, Tops Revenue Estimates
09:49pm, Monday, 28'th Mar 2022
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of 0% and 3.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results
08:01pm, Monday, 28'th Mar 2022 GlobeNewswire Inc.
RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its fina
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript
07:48pm, Monday, 28'th Mar 2022
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q4 2021 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results
04:01pm, Monday, 28'th Mar 2022
RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financ
Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops
01:00pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
Company poised for continued growth in a $6+ billion market¹ Company poised for continued growth in a $6+ billion market¹
Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops
09:00am, Thursday, 24'th Mar 2022
Company poised for continued growth in a $6+ billion market¹ Company poised for continued growth in a $6+ billion market¹
